| Old | New | Differences | |
|---|---|---|---|
| 1 | 1 | ||
| 2 | 2 | ||
| 3 | 3 | LCO No. 454 1 of 1 | |
| 4 | 4 | ||
| 5 | 5 | General Assembly Proposed Bill No. 150 | |
| 6 | 6 | January Session, 2025 | |
| 7 | 7 | LCO No. 454 | |
| 8 | 8 | ||
| 9 | 9 | ||
| 10 | 10 | Referred to Committee on GENERAL LAW | |
| 11 | 11 | ||
| 12 | 12 | ||
| 13 | 13 | Introduced by: | |
| 14 | 14 | SEN. SAMPSON, 16th Dist. | |
| 15 | 15 | (By Request) | |
| 16 | 16 | ||
| 17 | 17 | ||
| 18 | 18 | ||
| 19 | 19 | ||
| 20 | 20 | AN ACT CONCERNING DRUGS PRESCRIBED TO TREAT | |
| 21 | 21 | ATTENTION-DEFICIT/HYPERACTIVITY DISORDER. | |
| 22 | 22 | Be it enacted by the Senate and House of Representatives in General | |
| 23 | 23 | Assembly convened: | |
| 24 | 24 | ||
| 25 | 25 | That chapter 400j of the general statutes be amended to provide that 1 | |
| 26 | 26 | a pharmacist shall dispense a drug prescribed to treat attention-2 | |
| 27 | 27 | deficit/hyperactivity disorder if the patient (1) has a valid prescription 3 | |
| 28 | 28 | for such drug, and (2) provides to the pharmacist a quantitative 4 | |
| 29 | 29 | electroencephalogram brain map produced for the patient. 5 | |
| 30 | 30 | Statement of Purpose: | |
| 31 | 31 | To further specify the circumstances in which a pharmacist shall | |
| 32 | 32 | dispense a drug prescribed to treat attention-deficit/hyperactivity | |
| 33 | 33 | disorder. |